Dassault Aviation SA (AM)
Euronext Paris · France · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 304.60 |
|---|---|
| 52-week range | 260.80 – 361.80 |
| Return, 1 month / 3 months | +4.1% / −0.1% |
| Return, 1 year / 3 years | +11.0% / +71.7% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 29.9% |
| Worst drawdown (1 year) | -20.8% |
| Average daily value traded | 15.83M EUR |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dassault Aviation is a French aerospace company that designs and builds military aircraft and business jets. Its combat aircraft, including the Rafale, serve the French armed forces and export customers, while its Falcon family of business jets carries corporate and private clients. The company also provides support and maintenance services for its aircraft fleets. It is based in France and is controlled by the Dassault group.
On this site Dassault Aviation SA appears as a stock on the Euronext Paris (France), code AM, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dassault Aviation SA (AM) trades on the Euronext Paris in France. It last closed at EUR 304.60 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 86 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.0% and over the last three months it fell 0.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.2% | ||
| From 52-week high | -13.8% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -0.1% | ||
| 6-month return | 6.2% | ||
| 12-month return, skipping the last month | 6.7% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.8% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 15.83M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | +4.1% |
| 3 months | −0.1% |
| 6 months | +6.2% |
| 1 year | +11.0% |
| 3 years | +71.7% |
| 5 years | +267.5% |
Signals
| 50-day / 200-day average | 289.20 / 304.01 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | EUR 4.7800 |
| 20 May 2025 | EUR 4.7200 |
| 20 May 2024 | EUR 3.3700 |
| 22 May 2023 | EUR 3.0000 |
| 23 May 2022 | EUR 2.4900 |
| 18 May 2021 | EUR 12.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.